Human immunodeficiency virus as a determinant of tuberculosis treatment outcome in tuberculosis patients treated at Arba Minch General Hospital: a five-year retrospective study

Objective This study assessed the outcome of tuberculosis treatment and associated factors in Bale Zone, Southeast Ethiopia in 2017. Methods This was 5-year retrospective study of a health registry for tuberculosis patients, which was reviewed from 1 September 2011 to 30 August 2016. Data were analyzed, and descriptive and logistic regression analyses were used to identify the factors that were associated with tuberculosis treatment outcomes. Results Among the 7205 tuberculosis patients, 6325 (87.8%) had a successful treatment outcome and 880 (12.2%) had an unsuccessful outcome. The age groups ≤14 years (adjusted odds ratio [AOR]=2.21), 15 to 24 years (AOR=1.61), 25 to 34 years (AOR=1.86), or 35 to 44 years (AOR=1.65); being treated at a hospital (AOR=1.63) or health center (AOR=2.52); pulmonary tuberculosis-positive (AOR=0.80); or extrapulmonary tuberculosis patients (AOR= 0.78) were the factors that were significantly associated with tuberculosis treatment outcome. Conclusions Public health facilities should pay special attention to the identified variables for tuberculosis prevention and control activities, especially focusing on supporting health workers who work at a health post (lowest level of Ethiopia’s three-tiered healthcare system).

Download Full-text

Cutaneous adverse drug reaction in Human Immunodeficiency virus patient associated with antiviral therapy: A retrospective study

Dermatology Reports ◽

10.4081/dr.2019.8059 ◽

2019 ◽

Author(s):

Vidyani Adiningtyas ◽

Cita Rosita Sigit Prakoeswa ◽

Erwin Astha Triyono

Keyword(s):

Human Immunodeficiency Virus ◽

Adverse Drug Reaction ◽

Drug Reaction ◽

Retrospective Study ◽

Antiviral Therapy ◽

General Hospital ◽

Maculopapular Rash ◽

Clinical Feature ◽

Hiv Patients ◽

Immunodeficiency Virus

Drug hypersensitivity reactions specifically cutaenous adverse drug reaction (CADR) occur at higher rate in human immunodeficiency virus (HIV)- positive patients than general population and cause significant morbidity, in early era of antiretroviral therapy (ART), the incidence of skin rashes can reach 50% in HIV patients taking HIV medications. The purpose of this study is to evaluate the pattern of CADR in HIV patients associated with ART. A retrospective study took data from medical record CADR in HIV patients associated with ART at HIV ward, Dr. Soetomo General Hospital Surabaya, since January 2013 until December 2015. During the period of three years, there were 20 CADR patients in at HIV ward, Dr. Soetomo General Hospital Surabaya. The most common patient was male, with the highest age group of 25-44 years old, and the most clinical feature found were maculopapular rash, and Steven Johnson Syndrome (SJS). The most common antiviral therapy were nevirapine. The number of CADR in HIV patient associated with ART cases increased. The most clinical feature were maculopapular rash followed by SJS, only few cases of toxic epidermal necrolysis.

Download Full-text